Editas Medicine, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | — | -4,490.8% | -4,559.7% |
| Jun 2017 | — | -843.2% | -853.7% |
| Sep 2017 | — | -425.8% | -423.4% |
| Dec 2017 | — | -993.8% | -986.9% |
| Mar 2018 | — | -803.6% | -787.9% |
| Jun 2018 | — | -537.9% | -525.3% |
| Sep 2018 | — | -112.0% | -105.0% |
| Dec 2018 | — | -429.0% | -409.4% |
| Mar 2019 | — | -1,511.0% | -1,413.7% |
| Jun 2019 | — | -1,530.0% | -1,450.0% |
| Sep 2019 | — | -898.9% | -856.1% |
| Dec 2019 | — | -320.9% | -307.5% |
| Mar 2020 | — | -814.5% | -659.2% |
| Jun 2020 | — | -291.6% | -219.3% |
| Sep 2020 | — | 14.3% | 12.4% |
| Dec 2020 | — | -576.9% | -547.3% |
| Mar 2021 | — | -875.3% | -872.9% |
| Jun 2021 | — | -14,617.7% | -14,579.4% |
| Sep 2021 | — | -633.4% | -630.7% |
| Dec 2021 | — | -333.7% | -332.3% |
| Mar 2022 | — | -749.5% | -746.0% |
| Jun 2022 | — | -852.5% | -840.2% |
| Sep 2022 | — | -136,952.4% | -132,681.0% |
| Dec 2022 | — | -970.6% | -929.1% |
| Mar 2023 | — | -517.3% | -497.8% |
| Jun 2023 | — | -1,527.3% | -1,395.6% |
| Sep 2023 | — | -940.1% | -843.7% |
| Dec 2023 | — | -39.9% | -31.4% |
| Mar 2024 | — | -5,902.3% | -5,458.1% |
| Jun 2024 | — | -14,016.2% | -13,178.8% |
| Sep 2024 | — | -107,649.2% | -101,870.5% |
| Dec 2024 | — | -152.2% | -148.3% |
| Mar 2025 | — | -1,635.1% | -1,633.5% |
| Jun 2025 | — | -1,440.6% | -1,487.8% |
| Sep 2025 | — | -325.4% | -333.0% |
| Dec 2025 | — | -31.3% | -22.7% |
| Mar 2026 | — | -883.2% | -882.4% |
| Jun 2026 | — | -156.0% | -153.3% |